TScan Therapeutics, Inc. (TCRX) Reports In-Line Q2 EPS
Go back to TScan Therapeutics, Inc. (TCRX) Reports In-Line Q2 EPS| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.92 | 52 Week High | $26.80 | |||
| Open | $0.92 | 52 Week Low | $23.00 | |||
| Day High | $0.92 | P/E | N/A | |||
| Day Low | $0.92 | EPS | $0.00 | |||
| Volume | 318 | |||||
